Showing results (101-110 of 279) with videos related to
Sort By:
Pageof 28
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 9, 2018
The Incidence of Brain Metastases in Stage IV ROS1-Rearranged Non-Small Cell Lung Cancer and Rate of Central Nervous System Progression on CrizotinibTejas Patil, Derek E Smith, Paul A Bunn, et al.Investigational New Drugs|January 20, 2010
A phase I dose-escalation, safety and pharmacokinetic study of the 2-methoxyestradiol analog ENMD-1198 administered orally to patients with advanced cancerQing Zhou, Daniel Gustafson, Sujatha Nallapareddy, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 23, 2016
Combined Pan-HER and ALK/ROS1/MET Inhibition with Dacomitinib and Crizotinib in Advanced Non-Small Cell Lung Cancer: Results of a Phase I StudyPasi A Jänne, Alice T Shaw, D Ross Camidge, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 24, 2024
Final Overall Survival and Long-Term Safety of Lorlatinib in Patients With ALK-Positive NSCLC From the Pivotal Phase 2 Study: A Brief ReportSai-Hong Ignatius Ou, Benjamin J Solomon, Benjamin Besse, et al.Cancer Chemotherapy and Pharmacology|October 31, 2012
Sunitinib combined with pemetrexed and cisplatin: results of a phase I dose-escalation and pharmacokinetic study in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer and mesotheliomaD Ross Camidge, Normand Blais, Derek J Jonker, et al.Investigational New Drugs|August 22, 2013
Sunitinib combined with pemetrexed and carboplatin in patients with advanced solid malignancies--results of a phase I dose-escalation studyNormand Blais, D Ross Camidge, Derek J Jonker, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 28, 2017
The Impact of Postoperative Radiotherapy for Thymoma and Thymic CarcinomaMatthew W Jackson, David A Palma, D Ross Camidge, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 9, 2021
A Phase 1 Study Evaluating Rovalpituzumab Tesirine in Frontline Treatment of Patients With Extensive-Stage SCLCChristine L Hann, Timothy F Burns, Afshin Dowlati, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
A phase I safety and pharmacokinetic study of the death receptor 5 agonistic antibody PRO95780 in patients with advanced malignanciesD Ross Camidge, Roy S Herbst, Michael S Gordon, et al.Clinical Lung Cancer|October 9, 2024
Use of Oncogene Overlap by Tissue-Based Next-Generation Sequencing to Explore the Mutational Landscape and Survival Impact of HER2, KRAS and MET Copy-Number Gain in Nonsmall Cell Lung CancerAlexander S Watson, Harris B Krause, Andrew Elliott, et al.Pageof 28